Posts tagged thrombolytic biologic drug
Microbix meets FDA on Kinlytic return to U.S. market

Microbix Biosystems (TSX:MBX) has consulted with the FDA regarding the company's plans to return its thrombolytic biologic drug, Kinlytic, to the U.S. market.

Read More